1 FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit! Oct 31, 2024
Read More Apparatus Biyze For The Treatment Of Chronic Lymphocytic Leukaemia And Marginal Zone Lymphoma Nov 05, 2024
Read More Apparatus Genkore Announces Collaboration With Us Company On In Vivo Gene Editing Therapies Nov 16, 2024
